Registry and DNA Biorepository for Patients With Hereditary Antithrombin Deficiency
Phase: Recruiting
Condition(s): Hereditary Antithrombin Deficiency
Other Study ID Number(s): ISTH Database
What Is the Purpose of This Study?
- To learn more about the natural history of this condition
- To analyze genetic defects that can cause antithrombin deficiency and correlate with the natural history of the disease
Who Can Take Part in This Study?
- Individuals ages 0-21 years with antithrombin deficiency
- History of blot clots (thrombosis) and antithrombin deficiency
- Individuals without history of thrombosis, with family history of antithrombin deficiency and known to have antithrombin deficiency
What Will Happen During This Study?
- Office visit for history, physical exam and consent for participation.
- During this visit, you will have about 5 mL (about 1 teaspoon) of blood drawn that will be saved at the biorepository for research purposes.
Principal Investigator
Discover More Research
Explore additional studies relating to cancerYour Might Also Be Interested In
Hematology, Oncology & Blood and Marrow Transplant
Our hematology, oncology, and blood and marrow transplant teams treat patients with all forms of cancer and blood disorders. Our specialists participate in collaborative research across the country and around the world to bring innovative treatments to our patients.
Research and Clinical Care: How They Work Together to Treat Children
In this 700 Children's blog post for parents, Nationwide Children's highlights how clinical research and clinical care work together as a key part of our strategic plan to achieve the best outcomes for children. Before delving into these elements work together, the post covers the basics of clinical research.
Stay Updated With Clinical Research. Follow @NCHClinicalResearch on Instagram!
Parents and caregivers can learn more about clinical research on our Instagram channel, @NCHClinicalResearch. You can be part of the clinical research that moves us forward in our journey to best outcomes for all children, everywhere.